92 related articles for article (PubMed ID: 15166258)
1. The N-methyl-D-aspartate receptor inhibitory potencies of aromatic inhaled drugs of abuse: evidence for modulation by cation-pi interactions.
Raines DE; Gioia F; Claycomb RJ; Stevens RJ
J Pharmacol Exp Ther; 2004 Oct; 311(1):14-21. PubMed ID: 15166258
[TBL] [Abstract][Full Text] [Related]
2. Differential modulation of human N-methyl-D-aspartate receptors by structurally diverse general anesthetics.
Solt K; Eger EI; Raines DE
Anesth Analg; 2006 May; 102(5):1407-11. PubMed ID: 16632818
[TBL] [Abstract][Full Text] [Related]
3. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
Frizelle PA; Chen PE; Wyllie DJ
Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008
[TBL] [Abstract][Full Text] [Related]
4. Volatile aromatic anesthetics variably impact human gamma-aminobutyric acid type A receptor function.
Kelly EW; Solt K; Raines DE
Anesth Analg; 2007 Nov; 105(5):1287-92, table of contents. PubMed ID: 17959956
[TBL] [Abstract][Full Text] [Related]
5. Anthraquinone polyamines: novel channel blockers to study N-methyl-D-aspartate receptors.
Kashiwagi K; Tanaka I; Tamura M; Sugiyama H; Okawara T; Otsuka M; Sabado TN; Williams K; Igarashi K
J Pharmacol Exp Ther; 2004 Jun; 309(3):884-93. PubMed ID: 14764657
[TBL] [Abstract][Full Text] [Related]
6. Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling.
Chen PE; Geballe MT; Stansfeld PJ; Johnston AR; Yuan H; Jacob AL; Snyder JP; Traynelis SF; Wyllie DJ
Mol Pharmacol; 2005 May; 67(5):1470-84. PubMed ID: 15703381
[TBL] [Abstract][Full Text] [Related]
7. Contrasting roles of the N-methyl-D-aspartate receptor in the production of immobilization by conventional and aromatic anesthetics.
Eger EI; Liao M; Laster MJ; Won A; Popovich J; Raines DE; Solt K; Dutton RC; Cobos FV; Sonner JM
Anesth Analg; 2006 May; 102(5):1397-406. PubMed ID: 16632817
[TBL] [Abstract][Full Text] [Related]
8. Role of N-methyl-D-aspartate receptors in gastric mucosal blood flow induced by histamine.
Tsai LH; Lee YJ; Wu JY
J Neurosci Res; 2004 Sep; 77(5):730-8. PubMed ID: 15352220
[TBL] [Abstract][Full Text] [Related]
9. Design of antagonists for NMDA and AMPA receptors.
Bolshakov KV; Kim KH; Potapjeva NN; Gmiro VE; Tikhonov DB; Usherwood PN; Mellor IR; Magazanik LG
Neuropharmacology; 2005 Aug; 49(2):144-55. PubMed ID: 15996563
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human alpha4beta2 neuronal nicotinic acetylcholine receptors by volatile aromatic anesthetics depends on drug hydrophobicity.
Solt K; Kelly EW; Cotten JF; Raines DE
Anesth Analg; 2010 Feb; 110(2):455-60. PubMed ID: 19917625
[TBL] [Abstract][Full Text] [Related]
11. Monoamines directly inhibit N-methyl-D-aspartate receptors expressed in Xenopus oocytes in a voltage-dependent manner.
Masuko T; Suzuki I; Kizawa Y; Kusama-Eguchi K; Watanabe K; Kashiwagi K; Igarashi K; Kusama T
Neurosci Lett; 2004 Nov; 371(1):30-3. PubMed ID: 15500961
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors.
Masuko T; Namiki R; Nemoto Y; Miyake M; Kizawa Y; Suzuki T; Kashiwagi K; Igarashi K; Kusama T
J Pharmacol Exp Ther; 2009 Nov; 331(2):522-30. PubMed ID: 19644042
[TBL] [Abstract][Full Text] [Related]
13. N-methyl-D-aspartate receptor antagonists enhance histamine neuron activity in rodent brain.
Faucard R; Armand V; Héron A; Cochois V; Schwartz JC; Arrang JM
J Neurochem; 2006 Sep; 98(5):1487-96. PubMed ID: 16923161
[TBL] [Abstract][Full Text] [Related]
14. The NMDA receptor complex: a long and winding road to therapeutics.
Wood PL
IDrugs; 2005 Mar; 8(3):229-35. PubMed ID: 15772895
[TBL] [Abstract][Full Text] [Related]
15. Probing the Mg2+ blockade site of an N-methyl-D-aspartate (NMDA) receptor with unnatural amino acid mutagenesis.
McMenimen KA; Dougherty DA; Lester HA; Petersson EJ
ACS Chem Biol; 2006 May; 1(4):227-34. PubMed ID: 17163677
[TBL] [Abstract][Full Text] [Related]
16. Molecular interactions of the type 1 human immunodeficiency virus transregulatory protein Tat with N-methyl-d-aspartate receptor subunits.
Chandra T; Maier W; König HG; Hirzel K; Kögel D; Schüler T; Chandra A; Demirhan I; Laube B
Neuroscience; 2005; 134(1):145-53. PubMed ID: 15964699
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of linear and cyclic polyamines on NMDA receptor activities.
Masuko T; Miyake M; Kusama-Eguchi K; Koike T; Kimura E; Kizawa Y; Kashiwagi K; Igarashi K; Kusama T
Neurochem Int; 2008 Jul; 53(1-2):38-44. PubMed ID: 18556092
[TBL] [Abstract][Full Text] [Related]
18. Dopamine D1 receptors co-distribute with N-methyl-D-aspartic acid type-1 subunits and modulate synaptically-evoked N-methyl-D-aspartic acid currents in rat basolateral amygdala.
Pickel VM; Colago EE; Mania I; Molosh AI; Rainnie DG
Neuroscience; 2006 Oct; 142(3):671-90. PubMed ID: 16905271
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory interactions of calcineurin (phosphatase 2B) and calmodulin on rat hippocampal NMDA receptors.
Rycroft BK; Gibb AJ
Neuropharmacology; 2004 Sep; 47(4):505-14. PubMed ID: 15380369
[TBL] [Abstract][Full Text] [Related]
20. Do N-methyl-D-aspartate receptors mediate the capacity of inhaled anesthetics to suppress the temporal summation that contributes to minimum alveolar concentration?
Dutton RC; Laster MJ; Xing Y; Sonner JM; Raines DE; Solt K; Eger EI
Anesth Analg; 2006 May; 102(5):1412-8. PubMed ID: 16632819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
